fda glp-1 compounding crackdown news today issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Compounding Crackdown: Semaglutide Regulatory

Summary Patients with type 2 diabetes and cardiovascular disease should be started on either a GLP-1RA, SGLT-i, or both in high-risk cases, while simultaneously tapering any prescribed insulin regimen

We take your medical history, assess the area, and talk through realistic expectations

Why is it so hard for Mori and Pasifika to access weight loss drugs

Healthcare providers recommend monitoring individuals for these minor effects and adjusting dosage if necessary to enhance comfort and adherence

Targeted inhibition of NNMT improves insulin responsiveness and may protect against diet-induced obesity. Hong et al., Nature Medicine Longevity and Anti-Aging Potential Because NAD is vital for DNA repair, circadian rhythm regulation, and mitochondrial health, 5-Amino-1MQ is being explored as a geroprotective agent especially when stacked with NAD boosters or sirtuin activators